California State Teachers Retirement System Rain Therapeutics Inc. Transaction History

California State Teachers Retirement System

$84.1 Billion
Q3 2024

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$0.84 - $1.22 $706 - $1,026	-841 Reduced 22.43%	2,909 $3,000
Q3 2023 Nov 14, 2023	SELL	$0.82 - $1.42 $1,560 - $2,702	-1,903 Reduced 33.66%	3,750 $3,000
Q2 2023 Aug 21, 2023	BUY	$1.09 - $9.93 $6,161 - $56,134	5,653 New	5,653 $6,000
Q2 2022 Aug 15, 2022	SELL	$2.21 - $5.56 $15,131 - $38,069	-6,847 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$5.07 - $13.68 $9,491 - $25,608	-1,872 Reduced 21.47%	6,847 $35,000
Q4 2021 Feb 15, 2022	BUY	$11.91 - $17.0 $48,783 - $69,632	4,096 Added 88.6%	8,719 $112,000
Q3 2021 Nov 15, 2021	SELL	$13.21 - $20.91 $74,438 - $117,827	-5,635 Reduced 54.93%	4,623 $69,000
Q2 2021 Aug 16, 2021	BUY	$15.08 - $20.3 $154,690 - $208,237	10,258 New	10,258 $159,000

Others Institutions Holding RAIN

# of Institutions

Shares Held

122K

Call Options Held

Put Options Held

View Full List

About Rain Therapeutics Inc.

Ticker RAIN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 18,837,400
Description
Rain Therapeutics Inc., a clinical-stage precision oncology company, engages in developing therapies that target oncogenic drivers in the United States. Its lead product candidate is milademetan, a small molecule oral inhibitor of mouse double minute 2, which is oncogenic in various cancers. The company is also developing milademetan which is in...

More about RAIN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.

Account